Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine effect of combined medication of sufentanil and dexmedetomidine in patient controlled analgesia after neurosurgery.


Clinical Trial Description

Sufentanil is a classical drug for postoperative analgesia. Dexmedetomidine is a commonly used α2-adrenergic receptor, and it helps provide sedation, analgesia and inhibition of sympathetic activation. The investigators propose to recruit 120 patients who is undergoing the arteriovenous malformation embolism operation in department of Neurosurgery. Patients will be randomly divided into 4 groups(control group, sufentanil and low dexmedetomidine dose group, sufentanil and middle dexmedetomidine dose group, sufentanil and high dexmedetomidine dose group), then the investigators select post-operative records to determine whether dexmedetomidine can take a positive role in neurosurgical analgesia. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02552459
Study type Interventional
Source First Affiliated Hospital, Sun Yat-Sen University
Contact Liu Yi, master
Phone 13632391455
Email liuyisysu@126.com
Status Recruiting
Phase Phase 4
Start date September 2015
Completion date December 2016

See also
  Status Clinical Trial Phase
Completed NCT00603694 - Hippocampal Radiation Exposure and Memory N/A
Completed NCT00389935 - Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding Phase 2
Recruiting NCT02625389 - Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. Phase 4
Active, not recruiting NCT02445430 - Genetics of Arteriovenous Malformations
Completed NCT00972790 - Scalp Nerve Blocks for Post-Craniotomy Pain N/A
Completed NCT00001364 - Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities N/A
Recruiting NCT02496013 - Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB Phase 1
Completed NCT03269734 - Evaluation of the Accuracy of the Vessel Navigator Tool for Catheterization of Supra-aortic Vessels - ARCHIBALD